Bank of New York Mellon Corp Purchases New Shares in Solventum Corporation $SOLV

Bank of New York Mellon Corp purchased a new position in shares of Solventum Corporation (NYSE:SOLV) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 796,626 shares of the company’s stock, valued at approximately $61,460,000.

A number of other institutional investors have also recently added to or reduced their stakes in SOLV. United Services Automobile Association purchased a new position in shares of Solventum during the 1st quarter valued at approximately $239,000. Woodline Partners LP increased its stake in shares of Solventum by 40.7% in the first quarter. Woodline Partners LP now owns 11,677 shares of the company’s stock worth $888,000 after buying an additional 3,377 shares during the last quarter. Intech Investment Management LLC raised its holdings in Solventum by 167.0% in the first quarter. Intech Investment Management LLC now owns 16,669 shares of the company’s stock valued at $1,268,000 after acquiring an additional 10,425 shares in the last quarter. First Trust Advisors LP raised its holdings in Solventum by 5.8% in the second quarter. First Trust Advisors LP now owns 257,727 shares of the company’s stock valued at $19,546,000 after acquiring an additional 14,151 shares in the last quarter. Finally, Marshall Wace LLP bought a new position in Solventum during the 2nd quarter valued at $766,000.

Analyst Ratings Changes

A number of brokerages have recently issued reports on SOLV. Wedbush upped their target price on shares of Solventum from $94.00 to $101.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. Piper Sandler lifted their price target on Solventum from $92.00 to $105.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. KeyCorp boosted their price objective on Solventum from $93.00 to $102.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Mizuho set a $113.00 price objective on Solventum in a research note on Thursday, August 6th. Finally, BTIG Research increased their target price on Solventum from $91.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Eight investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $91.64.

Solventum Stock Performance

Shares of SOLV stock opened at $91.59 on Thursday. The company has a market cap of $15.59 billion, a P/E ratio of 11.20, a PEG ratio of 1.18 and a beta of 0.60. The business has a 50 day moving average of $81.85 and a two-hundred day moving average of $75.35. Solventum Corporation has a 52 week low of $62.38 and a 52 week high of $92.71. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 1.00.

Solventum (NYSE:SOLV) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $1.91 by $0.64. Solventum had a return on equity of 25.09% and a net margin of 17.26%.The firm had revenue of $2.21 billion during the quarter, compared to the consensus estimate of $2.15 billion. During the same period in the prior year, the business earned $1.69 EPS. The firm’s revenue was up 2.2% on a year-over-year basis. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. As a group, analysts anticipate that Solventum Corporation will post 7.22 EPS for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.